{"id":4750,"date":"2024-02-08T11:31:19","date_gmt":"2024-02-08T03:31:19","guid":{"rendered":"https:\/\/regask.com\/?p=4750"},"modified":"2024-11-19T09:47:48","modified_gmt":"2024-11-19T01:47:48","slug":"consentimiento-informado-de-la-fda-riesgo-minimo","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/fda-informed-consent-minimal-risk\/","title":{"rendered":"La FDA de EE. UU. facilita el consentimiento informado para ensayos cl\u00ednicos de riesgo m\u00ednimo"},"content":{"rendered":"<div class=\"ewa-rteLine\">La FDA implementa la Ley de Curas del Siglo XXI: entra en vigencia 30 d\u00edas despu\u00e9s de la publicaci\u00f3n y garantiza los derechos y la seguridad de los sujetos humanos. La modificaci\u00f3n final de la norma permite excepciones para el consentimiento informado en investigaciones cl\u00ednicas de riesgo m\u00ednimo.<\/div>\n\t<div id=\"gap-780341971\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-780341971 {\n  padding-top: 40px;\n}\n<\/style>\n\t<\/div>\n\t\n\n\t<div id=\"col-461845842\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<a href=\"https:\/\/www.federalregister.gov\/documents\/2023\/12\/21\/2023-27935\/institutional-review-board-waiver-or-alteration-of-informed-consent-for-minimal-risk-clinical\" target=\"_blank\" class=\"button secondary is-link\" rel=\"noopener\" >\n\t\t<span>Leer m\u00e1s<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<a href=\"https:\/\/regask.com\/es\/contacto\/\" class=\"button secondary\" style=\"border-radius:10px;\">\n\t\t<span>Soporte de inteligencia regulatoria<\/span>\n\t<\/a>","protected":false},"excerpt":{"rendered":"<p>La FDA implementa la Ley de Curas del Siglo XXI: entra en vigencia 30 d\u00edas despu\u00e9s de la publicaci\u00f3n y garantiza los derechos y la seguridad de los sujetos humanos. La modificaci\u00f3n final de la norma permite excepciones para el consentimiento informado en investigaciones cl\u00ednicas de riesgo m\u00ednimo.<\/p>","protected":false},"author":39,"featured_media":4745,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[35],"tags":[271,281],"class_list":["post-4750","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-biotech-latest-insights","tag-clinical-trial","tag-informed-consent"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA Eases Informed Consent Rules | RegASK<\/title>\n<meta name=\"description\" content=\"The US FDA eases informed consent requirements for minimal-risk clinical trials. Stay updated with RegASK.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/consentimiento-informado-de-la-fda-riesgo-minimo\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"US FDA Eases Informed Consent for Minimal Risk Clinical Trials\" \/>\n<meta property=\"og:description\" content=\"The US FDA eases informed consent requirements for minimal-risk clinical trials. Stay updated with RegASK.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/consentimiento-informado-de-la-fda-riesgo-minimo\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-08T03:31:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-19T01:47:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png\" \/>\n\t<meta property=\"og:image:width\" content=\"688\" \/>\n\t<meta property=\"og:image:height\" content=\"626\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-informed-consent-minimal-risk\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-informed-consent-minimal-risk\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"US FDA Eases Informed Consent for Minimal Risk Clinical&hellip;\",\"datePublished\":\"2024-02-08T03:31:19+00:00\",\"dateModified\":\"2024-11-19T01:47:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-informed-consent-minimal-risk\\\/\"},\"wordCount\":77,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-informed-consent-minimal-risk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/US-FDA-to-waive-or-alter-elements-of-informed-consent-for-certain-Minimal-Risk-Clinical-Trials.png\",\"keywords\":[\"Clinical trial\",\"Informed consent\"],\"articleSection\":[\"Pharma and Biotech\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-informed-consent-minimal-risk\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/fda-informed-consent-minimal-risk\\\/\",\"name\":\"FDA Eases Informed Consent Rules | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-informed-consent-minimal-risk\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-informed-consent-minimal-risk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/US-FDA-to-waive-or-alter-elements-of-informed-consent-for-certain-Minimal-Risk-Clinical-Trials.png\",\"datePublished\":\"2024-02-08T03:31:19+00:00\",\"dateModified\":\"2024-11-19T01:47:48+00:00\",\"description\":\"The US FDA eases informed consent requirements for minimal-risk clinical trials. Stay updated with RegASK.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/fda-informed-consent-minimal-risk\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-informed-consent-minimal-risk\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/US-FDA-to-waive-or-alter-elements-of-informed-consent-for-certain-Minimal-Risk-Clinical-Trials.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/US-FDA-to-waive-or-alter-elements-of-informed-consent-for-certain-Minimal-Risk-Clinical-Trials.png\",\"width\":330,\"height\":300,\"caption\":\"Us Fda To Waive Or Alter Elements Of Informed Consent For Certain Minimal Risk Clinical Trials\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La FDA flexibiliza las normas sobre consentimiento informado | RegASK","description":"La FDA de EE. UU. flexibiliza los requisitos de consentimiento informado para ensayos cl\u00ednicos de riesgo m\u00ednimo. Mant\u00e9ngase actualizado con RegASK.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/consentimiento-informado-de-la-fda-riesgo-minimo\/","og_locale":"es_ES","og_type":"article","og_title":"US FDA Eases Informed Consent for Minimal Risk Clinical Trials","og_description":"The US FDA eases informed consent requirements for minimal-risk clinical trials. Stay updated with RegASK.","og_url":"https:\/\/regask.com\/es\/consentimiento-informado-de-la-fda-riesgo-minimo\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2024-02-08T03:31:19+00:00","article_modified_time":"2024-11-19T01:47:48+00:00","og_image":[{"width":688,"height":626,"url":"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_image":"https:\/\/regask.com\/wp-content\/uploads\/2021\/12\/food-with-trans-fat-fop-labelling.png","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Benoit Trouwaert","Est. reading time":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/fda-informed-consent-minimal-risk\/#article","isPartOf":{"@id":"https:\/\/regask.com\/fda-informed-consent-minimal-risk\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"US FDA Eases Informed Consent for Minimal Risk Clinical&hellip;","datePublished":"2024-02-08T03:31:19+00:00","dateModified":"2024-11-19T01:47:48+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/fda-informed-consent-minimal-risk\/"},"wordCount":77,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/fda-informed-consent-minimal-risk\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/01\/US-FDA-to-waive-or-alter-elements-of-informed-consent-for-certain-Minimal-Risk-Clinical-Trials.png","keywords":["Clinical trial","Informed consent"],"articleSection":["Pharma and Biotech"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/fda-informed-consent-minimal-risk\/","url":"https:\/\/regask.com\/fda-informed-consent-minimal-risk\/","name":"La FDA flexibiliza las normas sobre consentimiento informado | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/fda-informed-consent-minimal-risk\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/fda-informed-consent-minimal-risk\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/01\/US-FDA-to-waive-or-alter-elements-of-informed-consent-for-certain-Minimal-Risk-Clinical-Trials.png","datePublished":"2024-02-08T03:31:19+00:00","dateModified":"2024-11-19T01:47:48+00:00","description":"La FDA de EE. UU. flexibiliza los requisitos de consentimiento informado para ensayos cl\u00ednicos de riesgo m\u00ednimo. Mant\u00e9ngase actualizado con RegASK.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/fda-informed-consent-minimal-risk\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/fda-informed-consent-minimal-risk\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/01\/US-FDA-to-waive-or-alter-elements-of-informed-consent-for-certain-Minimal-Risk-Clinical-Trials.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/01\/US-FDA-to-waive-or-alter-elements-of-informed-consent-for-certain-Minimal-Risk-Clinical-Trials.png","width":330,"height":300,"caption":"Us Fda To Waive Or Alter Elements Of Informed Consent For Certain Minimal Risk Clinical Trials"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Habilitando decisiones regulatorias m\u00e1s inteligentes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"Benoit Trouwaert"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/4750","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=4750"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/4750\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/4745"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=4750"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=4750"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=4750"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}